相关实验视频

Updated: Jul 22, 2025

Establishing a Severe Corneal Inflammation Model in Rats Based on Corneal Epithelium Curettage Combined with Corneal Sutures
04:48

Establishing a Severe Corneal Inflammation Model in Rats Based on Corneal Epithelium Curettage Combined with Corneal Sutures

Published on: November 22, 2024

360

在Fuchs内皮角膜缩症中,TRPV1和免疫调节之间的交叉关系

Yuchen Cai1, Jin Chen1, Hao Sun1

  • 1Department of Ophthalmology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai, China.

Clinical immunology (Orlando, Fla.)
|July 23, 2023
PubMed

Insights

福克斯内皮角膜缩症 (FECD) 涉及暂时受体潜在化物1 (TRPV1) 和免疫细胞. 这项研究确定了与TRPV1相关的基因和途径,表明了FECD的新治疗点.

科学领域:

  • 眼科医生 眼科 眼科
  • 免疫学 免疫学 免疫学
  • 分子生物学分子生物学

背景情况:

  • 福克斯内皮角膜缩症 (FECD) 是全球角膜移植的主要原因.
  • 暂时受体潜在化物亚型1 (TRPV1) 和免疫调节在FECD病变发生中的作用尚不清楚.

研究的目的:

  • 调查TRPV1和FECD中相关的免疫反应的参与.
  • 确定关键的基因和途径,将TRPV1与FECD联系起来.

主要方法:

  • 使用了体外FECD模型与H2O2诱导.
  • 分析的基因表达微阵列数据集 (GSE142538,GSE112039,E-GEAD-399和564) 进行了分析.
  • 对与TRPV1相关的差异表达基因 (DEG) 进行了功能分析和体外验证.

主要成果:

  • 在体外FECD模型中,TRPV1被显著上调.
  • 在TRPV1表达和免疫细胞,特别是调节性T细胞 (Tregs) 之间观察到负相关性.
  • 确定了四个核心TRPV1相关基因 (MAPK14,GNB1,GNAQ,ARRB2),并涉及TRP调节的运输和炎症通路.

结论:

  • TRPV1和免疫调节在FECD病原发生过程中表现出潜在的交叉声.
  • 已确定的生物标志物和途径为FECD研究和治疗开发提供了一个新的框架.
抽象的

No abstract available in PubMed .

关键词:
福克斯内皮角膜缩症 福克斯内皮角膜缩症基因治疗是一种基因疗法.免疫的景观.监管T细胞监管T细胞暂时的受体潜在化物1 1

更多相关视频

In Vitro and In Vivo Models to Study Corneal Endothelial-mesenchymal Transition09:05

In Vitro and In Vivo Models to Study Corneal Endothelial-mesenchymal Transition

Published on: August 20, 2016

8.0K
Murine Corneal Transplantation: A Model to Study the Most Common Form of Solid Organ Transplantation09:03

Murine Corneal Transplantation: A Model to Study the Most Common Form of Solid Organ Transplantation

Published on: November 17, 2014

9.8K

相关概念视频

T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.1K